APEIRON BIOLOGICS AG – Trademark Portfolio
Entity Type: 99
APEIRON BIOLOGICS AG holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 5 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include AB, ACELLT, and T ACELLT APEIRON CELL THERAPIES.
Campus-Vienna-Biocenter 5
A-1030 Wien
Showing of trademarks Trademarks
Trademark Classifications
APEIRON BIOLOGICS AG's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does APEIRON BIOLOGICS AG have?
APEIRON BIOLOGICS AG has 10 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does APEIRON BIOLOGICS AG file in?
APEIRON BIOLOGICS AG files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are APEIRON BIOLOGICS AG's most well-known trademarks?
APEIRON BIOLOGICS AG's registered trademark portfolio includes well-known marks such as AB, ACELLT, and T ACELLT APEIRON CELL THERAPIES. These are among 3 currently registered trademarks in the portfolio.
What is APEIRON BIOLOGICS AG's trademark registration success rate?
APEIRON BIOLOGICS AG has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.